News | July 18, 2014

One Million ECGs Recorded with AliveCor Heart Monitor

July 18, 2014 — AliveCor announced that more than one million ECGs (electrocardiograms) have been recorded using the AliveCor heart monitor since the first ECG was recorded in January 2013. This significant and steady data flow reiterates the company's focus on the importance of data collection for heart health research. Anonymized and aggregated data from users can contribute to developing personalized insights that will help both patients and caregivers better manage and control their heart health. Additionally, there has been a 1,000 percent increase in overall recordings since last year.

"The AliveCor heart monitor has provided me with a sense of empowerment as I can use the device to monitor my heart anywhere and at anytime," said Lisa Vasquez, an AliveCor patient with atrial fibrillation. "Having the ability to share my ECGs with my healthcare provider and get immediate feedback has helped me better understand and take control of my own heart health."

"We are proud that we have reached this latest milestone. The secure data we have collected has been able to help us better understand cardiac health as we continue to innovate the AliveCor heart monitor," said Euan Thomson, president and CEO at AliveCor. "It is our hope that as we continue to research and develop new insights we can provide more patients and caregivers comprehensive information that will enable them to more fully understand and manage their heart health."

The AliveCor heart monitor is the only FDA-cleared mobile ECG recorder that supports both iPhone and Android mobile devices. It records, displays (when prescribed or used under the care of a physician), stores and transfers single-channel ECG rhythms wirelessly, using the free AliveECG app. With secure storage in the cloud, users can access their data confidentially anytime, anywhere, and can grant access to their physician. The Heart Monitor is available for purchase in the United States, the United Kingdom and Ireland by health professionals and consumers.

The product’s medical grade ECG recordings can also be shared directly with a physician, or sent to a U.S. board-certified cardiologist or a U.S.-based cardiac technician through a cloud-based ECG analysis service provided by AliveCor. In as little as 30 minutes users can receive expert reviews of their ECGs directly through the free AliveECG app, providing a more complete picture of their current heart health.

For more information: www.alivecor.com

Related Content

ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging| August 18, 2017
August 18, 2017 — The American Society of...
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG| August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
New Study Focuses on Protein Responsible For Increased Heart Disease Risk
News | Cardiac Diagnostics| August 03, 2017
August 3, 2017 — A study to reduce the strongest inherited...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Aug.
Philips released a new version of its iFR system that displays FFR readings as an overlay on live angiographic, angiogram images.

Philips released a new version of its iFR system that displays hemodynamic pressure drop points in an overlay on live angiographic images, matching up the iFR readings with corresponding lesions. The system is supposed to speed diagnostic decision making and help guide percutaneous revascularization procedures. 

Feature | FFR Catheters| July 31, 2017 | Dave Fornell
The gold standard for assessing the hemodynamic significance of coronary lesions to determine if they should be revas
Siemens Healthineers to Acquire Epocal from Alere
News | Point of Care Testing| July 26, 2017
Siemens Healthineers has entered into a definitive agreement to acquire Epocal Inc., a subsidiary of Alere Inc. Epocal...
New PET-CT Scan Improves Detection in Rare Cardiac Condition
News | PET-CT| July 25, 2017
Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests,...
3-D Vascular Ultrasound Quantifies Plaque Burden to Estimate Cardiovascular Risk
News | Cardiovascular Ultrasound| July 20, 2017
July 20, 2017 — In a large, first-of-its-kind population, researchers found an experimental technique known as...
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG| July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Overlay Init